Agenda Discovery Week Month

Curated for Me

Cell and Gene Therapy, Philadelphia Pharmaceutical Symposium 2017

SAPA-GP
Write a Review
Select your rating. ( ) ( ) ( ) ( ) ( )
Endorsed by Curators:
Dec 02 8:00AM - 4:30PM

va

vb

Agenda


Progress in the Delivery of ex vivo Cell and Gene Therapy Products

Joseph Tarnowski, Ph.D.,Senior Vice President, Cell and Gene Therapy, Platform Technology & Science, R&D, GlaxoSmithKline


Developing Gene Therapies for Rare Diseases, a History of Synery between Academia and Industry

Federico Mingozzi, Ph.D.,Chief Scientific Officer, Spark Therapeutics


T-Cell Receptor Engineered T-Cells as Cancer Therapeutics

Rafael Amado, M.D.,Chief Medical Officer, Adaptimmune


Novel CAR-T Targets & Technologies: Capital Efficient Strategies to Clinical Proof of Concept

Wyle Solomon, M.B.A.,Chief Executive Officer, iCell Gene Therapeutics


A Phase I Study to Evaluate the Safety of Multi-Antigen Stimulated Cell Therapy-I in Patients with Advanced Solid Tumors

Shell Li, M.D., M.S., Global Chief Medical Officer, Vice President, Global Clinical Development, HRYZ BIO TECH CO.


Solve the Supply Problem of Gene Therapy - AAV Manufacturing Technology Overview

Jeffrey Hung, Ph.D., M.B.A.,Chief Commercial Officer, Vigene Biosciences



Brain Repair with In Situ Glia-to-Neuron Conversion

Gong Chen, Ph.D.,Professor, Penn State University, Verne M. Willaman Chair in Life Sciences


New Therapeutic Platforms: More Platform Than You Think

Mike Naso, Ph.D., Scientific Director, Gene and Gene Modified Cell Therapy, Janssen Pharmaceutical


Gene-Engineered T-Cell Therapy Bench to Bedside and Back Again

Laura Johnson, Ph.D.,Senior Director, Head Translational Medicine, Oncology Cell Therapy, GlaxoSmithKline


Clinical Experience with ASOs in Neuromuscular Disease

Toby Ferguson, M.D., Ph.D., Medical Director, Neuromuscular Disease, Biogen


CRISPR/Cas9: Modification & Modulation of Genes

Glenn Cowley, Ph.D., Senior Principle Scientist, Head of Functional Genomics, Discovery Sciences, Janssen Pharmaceuticals


Using CRISPR/Cas9 to Generate Universal T cells and Improve Adoptive Immunotherapy Against Solid Tumors

Yangbing Zhao, M.D., Ph.D.,Director, T Cell Engineering Lab, Adjunct Associate Professor, University of Pennsylvania

Upcoming Events